Aethlon Medical, Inc.
AEMD
$4.66
$0.4510.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.60% | 71.83% | -256.45% | 37.48% | -9.16% |
| Total Depreciation and Amortization | 172.64% | -1.55% | 0.12% | -62.74% | 161.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.86% | -96.96% | 2,860.05% | 40.10% | -16.94% |
| Change in Net Operating Assets | -120.07% | 30.19% | 48.37% | -297.98% | -57.85% |
| Cash from Operations | 3.28% | -2.53% | 16.82% | 9.20% | -26.73% |
| Capital Expenditure | -- | -- | 200.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 200.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 38.89% | -86.21% | 59.15% | -86.84% | 25.49% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 69,379.63% | -100.23% | 33,326.76% | -86.84% | -100.07% |
| Foreign Exchange rate Adjustments | 140.65% | -545.83% | 82.35% | -366.67% | 492.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 220.33% | -352.96% | 133.74% | 8.11% | -160.97% |